NTLA ▲ +1.9% - Intellia Therapeutics, Inc. $NTLA - Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations 03-NOV-2026 08:00 AM ET